Explore Crystagen dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator data.
Crystagen is a synthetic four-amino-acid peptide (Lys-Glu-Asp-Gly) from the Khavinson 'bioregulator' family, sourced in research as a proposed immune peptide. It ships as a lyophilized powder reconstituted before use.
In the Khavinson framework, thymic peptide bioregulators are proposed to act through direct binding to gene-promoter DNA in thymic epithelial cells and peripheral immune cells, selectively modulating transcription of genes involved in T-cell differentiation, cytokine balance, and immune-senescence markers.[2] This proposed direct-DNA-binding mechanism is unconventional and has not been independently characterised outside the Khavinson group.
Russian single-site studies have reported Crystagen as an immune-supportive adjunct in elderly patients with recurrent infections and immune-senescence markers, with reported improvements in T-cell subset distributions and infection frequency versus standard care.[3] These studies are not blinded or placebo-controlled, and no Western Phase 2 or 3 trial has been registered.
Not FDA-approved for any indication. Sold in Russia as a non-prescription dietary peptide; research-grade injectable material elsewhere.
Crystagen has a reported half-life of ~few hours (bioregulator estimate). The pharmacokinetic reference models an interval of once daily; this is not a measured community cadence or a dosing recommendation. Cleared within hours with daily dosing, so there is no real systemic buildup. Like other bioregulators, a course's benefit is thought to persist afterward. Pharmacokinetic source: Russian peptide-bioregulator literature (Khavinson; Glu-Asp-Pro). It is catalogued under Anti-Aging Peptides on WPA.
7 Crystagen reconstitution calculations have been logged by the WPA community.
This is the lifetime header population. Each chart and its associated analysis below use their own selected period and denominator; frequency responses are a separate cohort.
These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.